Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
収録刊行物
-
- Journal of Clinical Investigation
-
Journal of Clinical Investigation 120 (11), 3953-3968, 2010-11-01
American Society for Clinical Investigation
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363951793651108096
-
- DOI
- 10.1172/jci43490
-
- ISSN
- 00219738
-
- データソース種別
-
- Crossref